If a patient's phenytoin (Dilantin) serum level is 46 µg/mL, for how many days should the medication be withheld?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Phenytoin Level of 46 µg/mL

Hold phenytoin completely until the level drops below 20 µg/mL, which will take approximately 5-10 days based on the patient's individual elimination kinetics, then resume at a reduced maintenance dose.

Understanding the Clinical Context

A phenytoin level of 46 µg/mL represents severe toxicity (therapeutic range: 10-20 µg/mL). At this concentration, the patient is at significant risk for:

  • Central nervous system toxicity (ataxia, nystagmus, confusion, depressed consciousness)
  • Prolonged hospitalization due to extended elimination time
  • Risk of falls and injury from confusion and ataxia 1

The dose-related adverse effects include ataxia, nystagmus, tremor, and somnolence 2.

Pharmacokinetic Considerations

The critical issue is phenytoin's zero-order (saturable) pharmacokinetics at toxic levels:

  • At therapeutic levels, phenytoin has a half-life averaging 22 hours (range: 7-42 hours) 3
  • However, at toxic concentrations like 46 µg/mL, the elimination becomes dramatically prolonged because the hepatic enzyme system becomes saturated 3, 1
  • This saturation means the drug is eliminated at a fixed rate rather than a percentage per unit time, causing disproportionately long elimination times 4

Specific Management Algorithm

Step 1: Immediate Actions

  • Discontinue phenytoin immediately
  • Assess for clinical signs of toxicity (nystagmus, ataxia, confusion, altered mental status)
  • Provide supportive care and fall precautions 1

Step 2: Monitoring Strategy

  • Check phenytoin levels every 2-3 days initially
  • Target: Resume therapy when level drops below 20 µg/mL (upper therapeutic limit)
  • Consider checking free phenytoin levels if available, as they correlate poorly with total levels and provide better assessment 5

Step 3: Estimating Time to Safe Levels

Based on the pharmacokinetic data:

  • From 46 µg/mL to 20 µg/mL requires elimination of 26 µg/mL
  • With zero-order kinetics at toxic levels, this typically takes 5-10 days 4
  • One case study showed a level of 60.2 mg/L took 204 hours (8.5 days) to drop below 20 mg/L 4

Therefore, expect to hold phenytoin for approximately 7-10 days, but individualize based on serial level monitoring.

Step 4: Resumption of Therapy

  • Once level drops below 20 µg/mL, restart at a reduced maintenance dose
  • Typical maintenance: 4-8 mg/kg/day in children, 300 mg/day in adults 3
  • Reduce initial restart dose by 25-50% given the recent toxicity
  • Recheck level in 5-7 days after restart (time to steady state) 3

Critical Pitfalls to Avoid

  1. Do not attempt to "calculate" exact elimination time using linear kinetics - phenytoin follows zero-order kinetics at toxic levels, making standard half-life calculations invalid 4, 1

  2. Do not restart therapy based on time alone - always confirm with measured levels, as elimination varies widely between patients 3

  3. Do not use enhanced elimination methods (hemodialysis, hemoperfusion, multiple-dose activated charcoal) - there is no evidence these improve outcomes in phenytoin toxicity 1

  4. Do not overlook drug interactions that may have precipitated the toxicity - review all medications, particularly those affecting CYP2C9 metabolism 6

  5. Monitor for hypoalbuminemia - if albumin is low, use the Winter-Tozer equation to calculate corrected phenytoin levels, as the measured total level may overestimate toxicity 7, 5

Alternative Considerations

If ongoing seizure control is needed during the holding period:

  • Consider levetiracetam as a bridging agent - it has no interaction with phenytoin, rapid onset, and superior safety profile 8
  • Levetiracetam can be loaded at 1,500 mg orally or up to 60 mg/kg IV 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.